nach oben

Erschienen in:

28.09.2016 | Original Article

Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study

verfasst von: M. Atteritano, E. Di Mauro, V. Canale, A. M. Bruzzese, C. A. Ricciardi, V. Cernaro, A. Lacquaniti, M. Buemi, D. Santoro

Erschienen in: Osteoporosis International | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Summary

In hemodialysis patients, vertebral fractures were associated with elevated sclerostin levels, suggesting that sclerostin could reflect bone fragility in these patients.

Introduction

Fragility fractures are common in hemodialysis patients. The aims of our study were to determine the prevalence of vertebral fracture and analyze associations between sclerostin serum levels and vertebral fractures in hemodialysis patients.

Methods

Ninety-two hemodialysis patients and 100 controls matched for age and sex were studied. Bone mineral density was measured by ultrasonography at non-dominant heel. The markers of bone turnover included serum osteocalcin, C-terminal telopeptide, and sclerostin. All participants underwent radiography of the thoracic and lumbar spine to ascertain the presence of vertebral fractures.

Results

Bone ultrasound parameters at calcaneus were significantly lower in hemodialysis patients compared with controls; bone turnover markers and parathyroid hormone level were significantly higher, while serum of 25-OH-D3 was significantly lower in hemodialysis group. One or more moderate or severe vertebral fractures were found in 38 hemodialysis patients, whereas in control group, 10 patients had a vertebral fracture. In hemodialysis group, the comparison between patients with and without vertebral fractures showed that the patients with vertebral fractures had the serum sclerostin levels statistically higher than patients without vertebral, while serum levels of 25-OH-D3 was significantly lower in patients with vertebral fractures compared to the patients without vertebral fractures. Multivariate analysis disclosed that sclerostin levels were associated with an increased risk of vertebral fractures in hemodialysis patients after adjusting for multiple variables.

Conclusions

Our data shows high prevalence of vertebral fractures in hemodialysis patients and that it is associated with elevated sclerostin levels, reflecting bone fragility in these patients.

Trombetti A, Stoermann C, Chevalley T, Van Rietbergen B, Herrmann FR, Martin PY, Rizzoli R (2013) Alterations of bone microstructure and strength in end-stage renal failure. Osteoporos Int 24:1721–1732CrossRefPubMed

Grzegorzewska AE, Mlot M (2007) Influence of age and sex on bone mineral density in dialysis patients. Adv Perit Dial 23:77–81PubMed

Dooly AC, Weiss NS, Kestenbaum B (2008) Increased risk of hip fracture among men with CKD. Am J Kidney Dis 51:38–44CrossRef

Alem AM, Sherrard DJ, Gillen DL, Weiss NS, Beresford SA, Heckbert SR et al (2000) Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int 58:396–399CrossRefPubMed

Jadoul M, Albert JM, Akiba T, Akizawa T, Arab L, Bragg-Gresham JL et al (2006) Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the dialysis outcomes and practice patterns study. Kidney Int 70(7):1358–1366CrossRefPubMed

Fusaro M, Tripepi G, Noale M, Vajente N, Plebani M, Zaninotto M et al (2013) High prevalence of vertebral fractures assessed by quantitative morphometry in hemodialysis patients, strongly associated with vascular calcifications. Calcif Tissue Int 93(1):39–34CrossRefPubMed

Maeno Y, Inaba M, Okuno S, Kohno K, Maekawa K, Yamakawa T et al (2009) Significant association of fracture of the lumbar spine with mortality in female hemodialysis patients: a prospective observational study. Calcif Tissue Int 85(4):310–316CrossRefPubMed

Rodriguez-Garcia M, Gomez-Alonso C, Naves-Diaz M, Diaz-Lopez JB, Diaz-Corte C, Cannata-Andia JB (2009) Asturias study group vascular calcifications, vertebral fractures and mortality in haemodialysis patients. Nephrol Dial Transplant 24:239–246CrossRefPubMed

Stehman-Breen CO, Sherrad DJ, Alem AM, Gillen DL, Heckbert SR, Wong CS et al (2000) Risk factors for hip fracture among patients with end-stage renal disease. Kidney Int 58:2200–2205CrossRefPubMed

10.

Iimori S, Mori Y, Akita W, Kuyama T, Takada S, Asai T et al (2012) Diagnostic usefulness of bone mineral density and biochemical markers of bone turn-over in predicting fracture in CKD stage 5D patients: a single-center cohort study. Nephrol Dial Transplant 27:345–351CrossRefPubMed

11.

Baron R, Rawadi G, Roman-Roman S (2006) Wnt signaling: a key regulator of bone mass. Curr Top Dev Biol 76:103–127CrossRefPubMed

12.

Li X, Zhang Y, Kang H, Liu W, Liu P, Zhang J et al (2005) Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem 280:19883–19887CrossRefPubMed

13.

Poole KE, van Bezooijen RL, Loveridge N, Hamersma H, Papapoulos SE, Löwik CW, Reeve J (2005) Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. FASEB J 19:1842–1844PubMed

14.

Arasu A, Cawthon PM, Lui LY, Do TP, Arora PS, Cauley JA et al (2012) Study of osteoporotic fractures research group serum sclerostin and risk of hip fracture in older Caucasian women. J Clin Endocrinol Metab 97(6):2027–2032CrossRefPubMedPubMedCentral

15.

Pelletier S, Confavreux CB, Haesebaert J, Guebre-Egziabher F, Bacchetta J, Carlier MC et al (2015) Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients? Osteoporos Int 26(8):2165–2174CrossRefPubMed

16.

Genant HK, CY W, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148CrossRefPubMed

17.

Kauppila L, Polak J, Cupples L, Hannan M, Kiel D, Wilson P (1997) New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis 132:245–250CrossRefPubMed

18.

Fishbane S, Hazzan AD, Jhaveri KD, Ma L, Lacson E Jr (2016) Bone parameters and risk of hip and femur fractures in patients on hemodialysis. Clin J Am Soc Nephrol 29:09280915

19.

Wagner J, Jhaveri KD, Rosen L, Sunday S, Mathew AT, Fishbane S (2014) Increased bone fractures among elderly United States hemodialysis patients. Nephrol Dial Transplant 29(1):146–151CrossRefPubMed

20.

Fusaro M, Tripepi G, Noale M, Plebani M, Zaninotto M, Piccoli A et al (2015) Vertebral fractures and vascular calcifications study group. Prevalence of vertebral fractures, vascular calcifications, and mortality in warfarin treated hemodialysis patients. Curr Vasc Pharmacol 13(2):248–258CrossRefPubMed

21.

Fusaro M, Noale M, Viola V, Galli F, Tripepi G, Vajente N et al (2012) Vitamin K, vertebral fractures, vascular calcifications, and mortality: VItamin K Italian (VIKI) dialysis study. J Bone Miner Res 27(11):2271–2278CrossRefPubMed

22.

Bauer DC, Glüer CC, Genant HK, Stone K (1995) Quantitative ultrasound and vertebral fracture in postmenopausal women. J Bone Miner Res 10:353–358CrossRefPubMed

23.

Bauer DC, Glüer CC, Cauley JA, Vogt TM, Ensrud KE, Genant HK, Black DM (1997) Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women. A prospective study Study of Osteoporotic Fractures Research Group Arch Intern Med 157:629–634PubMed

24.

Bauer DC, Ewing SK, Cauley JA, Ensrud KE, Cummings SR, Orwoll ES (2007) Quantitative ultrasound predicts hip and non-spine fracture in men: the MrOS study. Osteoporos Int 18:771–777CrossRefPubMed

25.

Ambrus C, Almasi C, Berta K, Deak G, Marton A, Molnar MZ et al (2011) Vitamin D insufficiency and bone fractures in patients on maintenance hemodialysis. Int Urol Nephrol 43(2):475–482CrossRefPubMed

26.

Nickolas TL, Leonard MB, Shane E (2008) Chronic kidney disease and bone fracture: a growing concern. Kidney Int 74(6):721–731CrossRefPubMedPubMedCentral

27.

El Maghraoui A, Ouzzif Z, Mounach A, Rezqi A, Achemlal L, Bezza A et al (2012) Hypovitaminosis D and prevalent asymptomatic vertebral fractures in Moroccan postmenopausal women. BMC Womens Health 24:12–11

28.

Pelletier S, Dubourg L, Carlier MC, Hadj-Aissa A, Fouque D (2013) The relation between renalvfunction and serum sclerostin in adult patients with CKD. Clin J Am Soc Nephrol 8:819–823CrossRefPubMedPubMedCentral

29.

Polyzos SA, Anastasilakis AD, Bratengeier C, Woloszczuk W, Papatheodorou A, Terpos E (2012) Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women—the six-month effect of risedronate and teriparatide. Osteoporos Int 23:1171–1176CrossRefPubMed

30.

Amrein K, Amrein S, Drexler C et al (2012) Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults. J Clin Endocrinol Metab 97:148–154CrossRefPubMed

31.

Modder UI, Hoey KA, Amin S et al (2011) Relation of age, gender, and bone mass to rcirculating sclerostin levels in women and men. J Bone Miner Res 26:373–379CrossRefPubMed

32.

Arasu A, Cawthon PM, Cummings SR et al (2012) Serum sclerostin and risk of hip fracture in older Caucasian women. J Clin Endocrinol Metab 97:2027–2032CrossRefPubMedPubMedCentral

33.

Ardawi MS, Rouzi AA, Al-Sibiani SA, Al-Senani NS, Qari MH, Mousa SA (2012) High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the Center of Excellence for osteoporosis research study. J Bone Miner Res 27:2592–2602CrossRefPubMed

34.

Garnero P, Sornay-Rendu E, Munoz F, Borel O, Chapurlat RD (2013) Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study. Osteoporos Int 24(2):489–494CrossRefPubMed

35.

Szulc P, Bertholon C, Borel O, Marchand F, Chapurlat R (2013) Lower fracture risk in older men with higher sclerostin concentration: a prospective analysis from the MINOS study. J Bone Miner Res 28:855–864CrossRefPubMed

36.

Cejka D, Herberth J, Branscum AJ, Fardo DW, Monier-Faugere MC, Diarra D et al (2011) Sclerostin and Dickkopf-1 in renal osteodystrophy. Clin J Am Soc Nephrol 6(4):877–882CrossRefPubMedPubMedCentral

37.

Sabbagh YL, Graciolli FG, O’Brien S, Tang W, dos Reis LM, Ryan S, Phillips L, Boulanger J, Song W, Bracken C, Liu S, Ledbetter S, Dechow P, Canziani ME, Carvalho AB, Jorgetti V, Moyses RM (2012) Schiavi SC (2012) repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy. J Bone Miner Res 27(8):1757–1772CrossRefPubMed

38.

Morales-Santana S, Garcia-Fontana B, Garcia-Martin A, Rozas-Moreno P, Garcia-Salcedo JA, Reyes-Garcia R, Munoz-Torres M (2013) Atherosclerotic disease in type 2 diabetes is associated with an increase in sclerostin levels. Diabetes Care 36:1667–1674CrossRefPubMedPubMedCentral

39.

Winkler DG, Sutherland MK, Geoghegan JC, Yu C, Hayes T, Skonier JE, Shpektor D et al (2003) Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J 22(23):6267–6276CrossRefPubMedPubMedCentral

40.

Hampson G, Edwards S, Conroy S, Blake GM, Fogelman I, Frost ML (2013) The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in postmenopausal women. Bone 56:42–47CrossRefPubMed

41.

Zhu D, Mackenzie NC, Millán JL, Farquharson C, MacRae VE (2011) The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells. PLoS One 6(5):e19595CrossRefPubMedPubMedCentral

42.

Evenepoel P, D’Haese P, Brandenburg V (2015) Sclerostin and DKK1: new players in renal bone and vascular disease. Kidney Int 88(2):235–240 ReviewCrossRefPubMed

43.

Evrard S, Delanaye P, Kamel S, Cristol JP, Cavalier E (2015) SFBC/SN joined working group on vascular calcifications. Vascular calcification: from pathophysiology to biomarkers. Clin Chim Acta 438:401–414CrossRefPubMed

Titel: Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study
verfasst von: M. Atteritano
E. Di Mauro
V. Canale
A. M. Bruzzese
C. A. Ricciardi
V. Cernaro
A. Lacquaniti
M. Buemi
D. Santoro
Publikationsdatum: 28.09.2016
Verlag: Springer London
Erschienen in: Osteoporosis International / Ausgabe 2/2017
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-016-3770-9

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

18.04.2024 | Wirbelsäulenmetastase | Nachrichten

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study

Abstract

Summary

Introduction

Methods

Results

Conclusions

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

Brustkrebs in der Vorgeschichte macht Gelenkersatz komplikationsträchtiger

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Update Orthopädie und Unfallchirurgie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Summary

Introduction

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2017

Bone mineral density and microarchitecture in patients with essential thrombocythemia and polycythemia vera

Incident atrial fibrillation and the risk of fracture in the cardiovascular health study

Do osteoporotic fractures constitute a greater recalcitrant challenge for skeletal regeneration? Investigating the efficacy of BMP-7 and zoledronate treatment of diaphyseal fractures in an open fracture osteoporotic rat model

Differences in bone quality and strength between Asian and Caucasian young men

Evaluation on the cost-effective threshold of osteoporosis treatment on elderly women in China using discrete event simulation model

The role of calcium supplementation in healthy musculoskeletal ageing

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

Brustkrebs in der Vorgeschichte macht Gelenkersatz komplikationsträchtiger

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Update Orthopädie und Unfallchirurgie